American Journal of Cardiology
Volume 99, Issue 6, Supplement 1 , Pages S44-S46, 19 March 2007

Expert Opinion: Omega-3 Fatty Acids and Bleeding—Cause for Concern?

  • William S. Harris, PhD

      Affiliations

    • Corresponding Author InformationAddress for reprints: William S. Harris, PhD, Department of Medicine, Sanford School of Medicine of the University of South Dakota, 1400 West 22nd Street, Sioux Falls, South Dakota 57105.

Sanford School of Medicine of the University of South Dakota, Sioux Falls, South Dakota, USA.

published online 30 November 2006.

Omega-3 fatty acid ethyl esters have well-known triglyceride-lowering properties and were shown >30 years ago to inhibit platelet function. With the recent US Food and Drug Administration (FDA) approval of these agents for treating severe triglyceride elevations, concerns about excess bleeding naturally arise. However, an objective assessment of the evidence for clinically significant bleeding reveals that such concerns are unfounded. As such, the benefits of triglyceride lowering with omega-3 fatty acids more than outweigh any theoretical risks for increased bleeding.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-9149(06)02239-9

doi:10.1016/j.amjcard.2006.11.021

American Journal of Cardiology
Volume 99, Issue 6, Supplement 1 , Pages S44-S46, 19 March 2007